Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Gemma Donovan
Has grant
Head of Digital Therapeutics Development
Research Interests
Explore related searches
About
Gemma Donovan is the Head of Digital Therapeutics Development at Generated Health in the UK. Her research focuses on improving medication adherence through innovative digital solutions, with recent publications exploring automated text messaging support and the impact of digital communication on medication-taking behaviors. Additionally, she has conducted qualitative studies on prescribing error reporting in primary care. Her work aims to enhance patient outcomes and address challenges in long-term condition management.
Recent Grants
Grant: Close
Understanding prescribing practices and the factors that influence decision making by health care professionals when prescribing opioids for patients with acute pain
Open Date: 2021-08-01
Close Date: 2022-12-01
Grant: Close
Deprescribing in Primary Care: Getting started
Open Date: 2019-05-01
Close Date: 2019-10-01
Grant: Close
Prescribing error reporting: Facilitating learning and patient safety across primary care (PREPARE)
Open Date: 2019-05-01
Close Date: 2019-09-01
Grant: Close
A Text message Intervention to support MEdicines adherence mobiLised though community pharmacY (TIMELY)
Open Date: 2016-10-01
Close Date: 2021-09-01
Grant: Close
Clinical And genetic determinants of Thyroid Hormone Replacement IN general practicE (CATHRINE)
Open Date: 2015-05-01
Close Date: 2016-11-01
Articles (3)
Purpose Around half of prescribed medications for long‐term conditions are not taken as directed. Automated two‐way digital communication, such as text messaging and interactive voice response technology, could deliver interventions to improve medication adherence, and subsequently health. However, exploration of how such interventions may improve medication adherence is limited. This review aimed to explore how automated two‐way digital communication can improve medication taking with or without using non‐digital intervention components, such as phone calls with healthcare professionals. Methods A theory‐informed narrative synthesis systematic review. Several databases were searched including CINAHL, Embase, Medline, and Web of Science using key words relating to ‘medication adherence’ and digital communication technologies. The Behavior Change Technique (BCT) coding using the BCT Taxonomy V1 and the Behavior Change Wheel were used to identify BCTs delivered within the included interventions. Results A total of 3,018 records were screened with 43 study reports included in the review. Four medication‐taking behaviors: taking medication , obtaining medication , self‐testing, and asking for support were identified as targets for behavior change within the included interventions. Most BCTs within the digital communication component aimed to increase motivation for medication adherence, with non‐digital intervention components included to address other medication taking barriers, such as physical and psychological capability. Conclusion Automated two‐way digital communication can detect barriers to medication adherence by monitoring performance of the taking medication behavior. Monitoring outcomes from taking medication may increase reflective motivation to take medicines. Addressing physical opportunity to taking medication by facilitating the behavior obtaining medication may also increase adherence.
Year:
2022
Year:
2022
Year:
2022
Collaborators (1)
Scott Wilkes
Professor of General Practice and Primary Care
University of Sunderland
Make your next move.
Prepare your application
Review drafts before you send them.